ZA978948B - Novel therapeutically active adenosine derivatives. - Google Patents

Novel therapeutically active adenosine derivatives.

Info

Publication number
ZA978948B
ZA978948B ZA9708948A ZA978948A ZA978948B ZA 978948 B ZA978948 B ZA 978948B ZA 9708948 A ZA9708948 A ZA 9708948A ZA 978948 A ZA978948 A ZA 978948A ZA 978948 B ZA978948 B ZA 978948B
Authority
ZA
South Africa
Prior art keywords
therapeutically active
adenosine derivatives
novel therapeutically
active adenosine
novel
Prior art date
Application number
ZA9708948A
Inventor
Lars Knutsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA978948B publication Critical patent/ZA978948B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9708948A 1996-10-14 1997-10-07 Novel therapeutically active adenosine derivatives. ZA978948B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK113696 1996-10-14

Publications (1)

Publication Number Publication Date
ZA978948B true ZA978948B (en) 1998-04-14

Family

ID=8101427

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708948A ZA978948B (en) 1996-10-14 1997-10-07 Novel therapeutically active adenosine derivatives.

Country Status (3)

Country Link
AU (1) AU4377397A (en)
WO (1) WO1998016539A1 (en)
ZA (1) ZA978948B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44900A (en) 1998-01-31 2003-01-31 Glaxo Group Limited 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
GB9813554D0 (en) 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
CN1313861A (en) 1998-06-23 2001-09-19 葛兰素集团有限公司 2-(purin-9-YL)-tetrahydrofuran-3,4-diolderivatives
GB0105469D0 (en) * 2001-03-06 2001-04-25 Glaxo Group Ltd Medicaments
GB0106867D0 (en) * 2001-03-20 2001-05-09 Glaxo Group Ltd Process
US7414036B2 (en) 2002-01-25 2008-08-19 Muscagen Limited Compounds useful as A3 adenosine receptor agonists
DE60315164T2 (en) * 2002-08-15 2008-04-30 CV Therapeutics, Inc., Palo Alto PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS
AR049384A1 (en) 2004-05-24 2006-07-26 Glaxo Group Ltd PURINA DERIVATIVES
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives

Also Published As

Publication number Publication date
WO1998016539A1 (en) 1998-04-23
AU4377397A (en) 1998-05-11

Similar Documents

Publication Publication Date Title
ZA961444B (en) Pyrazolylbenzoyl derivatives.
ZA9710156B (en) Antiviral peptide derivatives.
HK1075043A1 (en) Antivirally active heterocyclic azahexane derivatives
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA976777B (en) Anthelmintic formulations.
HUP9602745A3 (en) Anticelladhesive piperidine- und pyrrolidine-carbonacids, pharm
IL126095A0 (en) Azolobenzazepine derivatives as neurogically active agents
ZA961449B (en) Isoxazolylbenzoyl derivatives.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
ZA977807B (en) New pharmaceutically active compounds.
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
ZA96960B (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines
ZA966554B (en) Therapeutically Active Compounds.
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA967741B (en) Diarylalkenylamine derivatives.
ZA978948B (en) Novel therapeutically active adenosine derivatives.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA982436B (en) Thiazolimine derivatives.
ZA978086B (en) New pyranoside derivatives.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
ZA977809B (en) New pharmaceutically active compounds.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA964034B (en) N-aminopyridone derivatives.